Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
42.82
+0.82 (1.95%)
At close: Mar 6, 2026, 4:00 PM EST
43.00
+0.18 (0.42%)
After-hours: Mar 6, 2026, 7:53 PM EST
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $4.66 billion as of March 6, 2026. Its market cap has increased by 1,227.66% in one year.
Market Cap
4.66B
Enterprise Value
4.36B
1-Year Change
1,227.66%
Ranking
Category
Stock Price
$42.82
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $4.66B, an increase of 3,143.09%. That is a compound annual growth rate of 98.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.66B | 5.99% |
| Dec 31, 2025 | 4.39B | 833.82% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celcuity | 5.32B |
| Caris Life Sciences | 5.25B |
| CG Oncology | 5.23B |
| Mirum Pharmaceuticals | 5.21B |
| Scholar Rock Holding | 5.20B |
| PTC Therapeutics | 5.20B |
| Apogee Therapeutics | 5.03B |
| Erasca | 4.79B |